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Nitric oxide (NO, nitrogen monoxide) is one of the most unique biological signaling molecules associated
with a multitude of physiologic and pathological conditions. In order to fully appreciate its numerous roles,
it is essential to understand its basic biochemical properties. Most signaling effector molecules such as
steroids or proteins have a signiﬁcant life-span and function through classical receptor–ligand interactions.
NO, however, is a short-lived free-radical gas that only reacts with two types of molecules under biological
conditions; metals and other free radicals. These simple interactions can lead to a myriad of complex
intermediates which in turn have their own phenotypic effects. For these reasons, responses to NO often
appear to be random or contradictory when outcomes are compared across various experimental settings.
This article will serve as a brief overview of the chemical, biological, and microenvironmental factors that
dictate NO signaling with an emphasis on NO metabolism. The prominent role that oxygen (dioxygen,
O2) plays in NO metabolism and how it inﬂuences the biological effects of NO will be highlighted. This
information and these concepts are intended to help students and investigators think about the inter-
pretation of data from experiments where biological effects of NO are being elucidated.
& 2015 The Author. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Nitric oxide is a free radical, which is any molecule with an
unpaired electron. Before NO was found to be endogenously
synthesized in humans in the 1980s, most free radicals were lar-
gely thought to have deleterious biological effects [1]. For example.V. This is an open access article un
de and Cancer, edited by Jordioxygen-, nitrogen-, and carbon-centered radicals are strong oxi-
dants that can indiscriminately damage a host of macromolecules
including DNA, lipids, and proteins. The most notable examples
include the hydroxyl radical (OH), superoxide (O2−), nitrogen
dioxide (NO2), and carbonate anion radical ( CO2• −) [2]. Nitric
oxide, on the other hand, is considered a relatively stable free
radical and under biological conditions it only reacts with two
types of molecules: metals and other free radicals [3]. In this
context, NO is designated to be stable because it does not spon-
taneously decay or react with itself (dimerize) [4]. Although NOder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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another NO molecule to form N2O2 does not occur under biolo-
gical conditions based largely on entropic grounds [1].
Unlike other biologically relevant free radicals, NO does not
directly undergo one-electron oxidation/reduction reactions to
form the nitrosonium cation (NOþ) or nitroxyl anion (NO), or its
conjugate acid (HNO), respectively [5,6]. Although these species
can be formed via redox reactions between NO and metals or O2,
a signiﬁcant thermodynamic barrier precludes their direct for-
mation. For these reasons, NO is not considered a particularly
good oxidant or reductant. Nevertheless NO does rapidly react
with numerous cellular targets that contribute to its short biolo-
gical life-time, which in most circumstances is less than 2 s [7].
When compared to other signaling molecules, this is extremely
short. However, in relation to other free radicals, whose life-span is
often on the order of milliseconds, this is a relatively long time.
Being composed of only one atom of nitrogen and one atom of
oxygen, NO is one of the smallest known signaling molecules.
Although it is a free radical with an unpaired electron, it does not
possess an electrical charge. These are important properties
because they allow NO to readily cross biological membranes by
passive diffusion. In addition, NO is soluble in both hydrophobic
and hydrophilic environments. In fact, it is more soluble in
hydrophobic environments by a factor of about 10, which turns out
to be an important determinant of its biological actions and
reactivity [8].Biological targets of NO
Iron
As mentioned above, in a cellular setting, NO will only react
with transition metals and other free radicals. The majority of
NO/metal reactions involve ferrous iron (Fe2þ) and to a lesser
extent copper (Cuþ) [3]. There are several forms of iron in cells
and NO is known to react with all of them, albeit to varying
degrees. A large proportion of iron of exists in the form of heme
(iron protoporphyrin), where it is used for enzyme catalysis or to
transport O2. In erythrocytes and myocytes, the prominent heme-
containing proteins are hemoglobin and myoglobin. The main
function of these proteins is to transport dioxygen (O2), which
binds directly to the ferrous heme. In these proteins, NO can bind
reversibly to the ferrous heme in the absence of O2, or it can react
with an O2 bound to the heme [9]. The reaction and binding of NO
to reduced heme leads to the formation of iron-nitrosyls via a
process called nitrosylation Eq. (1). In the absence of O2, this is a
relatively stable bond. On the other hand, in the presence of O2, its
reaction with the NO-bound iron center converts it to nitrate
(NO3−) Eq. (2). Conversely, NO can react with oxyHb, which also
forms NO3− Eq. (3). Reactions (2) and (3) are extremely fast, dif-
fusion limited reactions, and result in the rapid scavenging of NO.
This is one of the main consumptive mechanisms of NO in the
vasculature [4].
Fe2þþNO-Fe2þNO (1)
Fe2þNOþO2-Fe3þþNO3 (2)
Fe2þO2þNO-Fe3þþNO3 (3)
In non-erythroid cells, the reactions of NO with heme-proteins
have important signaling consequences as opposed to merely
scavenging bioavailable NO. One of the most important examples
is the reaction of NO with soluble guanylyl cyclase (sGC). This
protein converts GTP to cGMP and binding of NO to its heme
center leads to a 100-fold increase in its catalytic activity [10].Another key population of cellular iron is “chelatable iron” or
the chelatable iron pool (CIP). This is iron in transition between
cellular uptake and incorporation into iron storage protein (ferri-
tin) or the catalytic site of enzymes. The CIP is methodologically
deﬁned as being the population of cellular iron that is accessible to
chemical iron chelators [11]. It is mostly cytosolic but also has
mitochondrial and nuclear components. The CIP is redox-active
and represents a small but chemically signiﬁcant population of
total cellular iron (o3%). The rapid reaction of NO with the CIP
and cellular thiols results in the formation of dinitrosyliron com-
plexes (DNIC, (RS)2Feþ(NOþ)2) Eq. (4) [12]. In fact, 100% of the
CIP is quantitatively converted into DNIC upon cellular exposure to
NO [13]. Moreover, DNIC are the most abundant population of
NO-derived cellular adducts, much more than S-nitrosothiols,
heme nitrosyls, or nitrotyrosine [14]. The consequences of DNIC
formation can range from iron sequestration and signaling to
participating in S-nitrosothiol (RSNO) formation [15–20].
Fe2þþ3NOþ2RSþHþ-{(RS)2Feþ(NOþ)2}þ½(N2OþH2O)
(4)
Cellular iron is also used for the activity of non-heme iron
oxygenases, which are important enzymes that catalyze a wide
variety of degretory and biosynthetic reactions. The source of iron
for these enzymes is the CIP [21–23]. Nitric oxide can bind
reversibly to the catalytic iron and inhibit a variety of these
enzymes to varying degrees. As O2 is the normal substrate for
these enzymes, the reaction of NO at the iron site is competitive
and it will depend on the relative concentrations of the two gases.
As a general rule, any protein that will bind O2 will also bind NO
(and CO) with either greater or lesser afﬁnity. This will depend on
the iron coordination and other bound ligands as well as the
oxidation state. Lastly, there are iron–sulfur proteins which are
used for redox and electron transfer reactions in a diverse set of
proteins. The interaction of NO with iron–sulfur proteins is
usually destructive but they may also be involved in the formation
of protein-bound DNIC [24,25].
Free radicals
Paired electrons are stable and nearly 100% of all electrons in
our bodies are paired. Just as NO reacts with iron and other
transition metals because they have unpaired elections (in their d
orbitals), NO reacts with free radicals because they possess
unpaired elections as well. In addition to NO, there are several
free radicals of biological interest. Superoxide (O2−) is probably the
most notable. Superoxide is the one electron reduction product of
O2 and it is formed as a natural byproduct of oxidative metabolism.
It is also the substrate for several types of enzymes as well as the
product; superoxide dismutase and xanthine oxidase, respectively.
The reaction of NO with O2− is near diffusion limited and the
product is peroxynitrite (ONOO) [26]. Peroxynitrite can go on to
react with numerous other molecules including NO and O2− [27].
In general, ONOO performs strong oxidative chemistry.
Depending on the relative ﬂux rates of NO and O2−, however, the
net effect of ONOO formation is a decrease in the concentrations
of both species. The most signiﬁcant effect of ONOO may simply
be attributed to scavenging of NO and O2−, thereby diminishing
their signaling capabilities [28]. There are other radical–radical
reactions with NO that have biological consequences (for detailed
reviews on oxidative stress see and NO reactivity see
[3,6,9,29,30]).
Nitric oxide production
In mammalian systems the dominant mode of NO production
is via enzymatic synthesis from one of three isoforms of nitric
Fig. 1. Oxygen determines the rate of NO production. (A) Enzymatic synthesis of NO is a function of O2 concentration. RAW 264.7 murine macrophages were cultured at 1%
or 21% O2 and stimulated with LPS (t¼0). Total NO synthesis was assessed by measuring NO /NO2- 3− in the media at the indicated time points by chemiluminescence.
(B) NOS independent mechanisms of NO synthesis.
D.D. Thomas / Redox Biology 5 (2015) 225–233 227oxide synthase (neuronal nNOS, inducible iNOS, and endothelial
eNOS, or NOSI, NOSII, and NOSIII, respectively). The differences
between each NOS are based on a variety of factors including their
tissue distributions as well as their modes of expression and reg-
ulation. nNOS and eNOS are constitutively expressed and generally
produce lower amounts of NO (nM) for short periods of time.
iNOS however is “inducible” and it becomes upregulated in
response to various stimuli including cytokines and bacterial
endotoxins. It is capable of producing greater amounts of NO for
prolonged periods of time. The NOS enzymes are ﬂavoproteins
that transfer electrons via NADH, FAD, FMN, and Fe2þ . They also
require the cofactor tetrahydrobiopterin (BH4). Substrates for NOS
enzymes are dioxygen (O2) and the amino acid L-arginine (Arg),
with the products being NO and the amino acid L-citrulline Eq. (5)
[31,32].
L Arg O NADPH L Cit NADP NO 52
NOS− + + → − + + ( )+ •
The amount of NO being synthesized from NOS depends on a
variety of factors including substrate and cofactor availability.
Posttranslational modiﬁcations, such as phosphorylation, as well
as tetrahydrobiopterin (BH4) availability can both inﬂuence the
rate of NO synthesis. For example, BH4 deﬁciency can result in
uncoupling of the enzyme and favor the generation of O2− [33].
Arginine is usually not a limiting substrate except in disease states
but other enzymes such as arginase can compete with NOS for its
availability. Under conditions where there is an abundance of
substrates and cofactors, the most signiﬁcant determinant of the
rate/amount of NO synthesis is the local O2 concentration. The KM
for O2 for each of the NOS isoforms varies widely (eNOS¼23 mM,
iNOS¼135 mM, and nNOS¼350 mM) [32]. At O2 concentrations
below the KM for O2, the rate of NO synthesized from each NOS
will be proportional to the O2 concentration and it will increase
linearly as the O2 concentration raises. For example, eNOS, with
the lowest KM, will maximally produce NO over a range of phy-
siologic O2 concentrations. For nNOS, however, the production of
NO will increase over a wide range of O2 concentrations. Fig. 1Ademonstrates how differences in O2 concentrations affect total NO
production from iNOS in cultured macrophages [34]. At 24 h, total
NO synthesis at 1% O2 is about half the amount that is produced
at 21% O2. This is what would be predicted as 1% O2 is well below
the KM for O2 for iNOS.
In addition to NO synthesis from NOS enzymes, there are
other biological mechanisms to generate NO. These include
nitrite reduction by heme proteins such as hemoglobin Eq. (6) as
well as enzymatic reduction of nitrite by non-NOS enzymes such
as xanthine oxidoreductase Eq. (7) (Fig. 1B) [35–37].
NO2 þHbFe2þþHþ-NOþHbFe3þþOH (6)
XOþNO2 þe--NO (7)
Unlike NOS-mediated NO synthesis which requires O2, the
generation of NO by the above reactions is enhanced at low O2.
They are thought to serve as compensatory mechanisms for NO
synthesis under hypoxic conditions. Nitric oxide can also be gen-
erated by the acidiﬁcation of nitrite in tissue compartments or
cellular organelles where the pH is low Eq. (8) [38]. This reaction is
known to occur in the low pH environment of the stomach from
dietary nitrite.
NO2 þHþ-HNO2, 2HNO2-N2O3þH2O, N2O3-NOþNO2 (8)
As far as total body NO synthesis, the above 3 mechanisms
appear to be minor contributors. However, they do account for the
physiologic and therapeutic effects of dietary and pharmacologic
nitrite. Although nitrate and nitrite were once thought to be car-
cinogenic, it is now becoming increasingly clear that the physio-
logic beneﬁts derived from their ability to generate NO far out-
weigh their deleterious properties [39].
Nitric oxide consumption
Although it is well understood how NO is produced under
biological conditions, much less is known about its mode of cat-
abolism. The half-life of NO is short (0.1–2 s), which is a function
Fig. 2. Oxygen determines the rate of NO catabolism. RAW 264.7 cells were trypsinized and suspended into a sealed, water-jacketed, temperature-controlled (37 °C)
reaction chamber with constant stirring. The reaction chamber was equipped with both NO and O2 electrodes connected to an Apollo 4000 free radical analyzer (World
Precision Instruments, Sarasota, FL, USA). Headspace in the vessel was negligible compared to the vessel volume to ensure that the rate of NO volatilization was insigniﬁcant
compared with its reaction in solution. Reactions were initiated by injection of a saturated NO solution with a gas-tight syringe, and NO metabolism was measured using
an NO-selective electrode (amiNO-700, Innovative Instruments, Tampa, FL, USA). (A) At time “0”, the cells were treated with a bolus of NO (200 nM) and the disappearance
of NO was measured over time. Or NO added to the reaction chamber in the absence of cell. (B) Disappearance of NO was measured in cells treated with 200 nM NO (at
21% O2) or the cells were allowed to consume O2 in the reaction chamber until a level of 1% O2 was achieved before the addition of NO. (C) The direct relationship between
the O2 concentration and the rate of NO metabolism.
D.D. Thomas / Redox Biology 5 (2015) 225–233228of the mechanisms by which NO is consumed by cells [7]. These
consumptive mechanisms are determined by the rate at which NO
reacts with various cellular targets. Although NO only reacts with
transition metals and other free radicals including O2, there are a
multitude of potential reactants that will differ based on the cell
type and local redox environment. Regardless of what the cellular
reactants are, cellular consumption of NO most likely is not
simply the result of stoichiometric reactions with cellular targets.
Continuous exposure to NO demonstrated that cells consume NO
at a constant rate which did not appear to be saturable [7]. This
indicates that the reactants for NO are either continuously pro-
duced or rapidly recycled. As mentioned above one well-known
reaction of NO is with oxyhemoglobin to form nitrate (NO3−) (Eqs.
(2) and (9)). This is an extremely rapid reaction and is the major
consumptive mechanism of NO in the vasculature.
NOþoxyHb-MetHbþNO3 (9)
In non-erythroid cells, however, there are a multitude of other
potential reactants for NO including radicals like superoxide
(O2−), which forms nitrate (NO3−), or hypervalent metal oxo species
(Fe4þ¼O), which form nitrite [9]. Nitric oxide will also react with
many heme and non-heme iron proteins as well as chelatable iron,
ultimately being oxidized to nitrate and nitrite. It is important to
point out that the exact mechanism(s) by which NO is metabo-
lized by cells is not precisely known. This is because NO has
numerous cellular targets and therefore the means by which it is
consumed is the sum of several dominant reactions. The con-
tribution of each reaction toward the rate of NO consumption is a
function of the rate of each reaction and the concentration of each
reactant. Fig. 2A demonstrates that when a bolus of 200 nM NO is
added to a suspension of cells, it disappears over time via itsreactions with various cellular targets. It can be seen that the rate
of NO disappearance in the presence of cells is much more rapid
than its disappearance in the absence of cells, which is known to
occur via a direct reaction with O2 in solution [7,34].
Although the types of speciﬁc cellular reactants for NO may
differ between cell types, research has shown that the pre-
dominant mechanisms of NO metabolism require O2 [7]. This is
illustrated in Fig. 2B, which demonstrates the rates of NO dis-
appearance in the presence of cells at two different O2 con-
centrations (21% and 1%). For the same number of cells, NO is
metabolized much more rapidly at 21% O2 than at 1% O2. There-
fore, there is a direct relationship between the O2 concentration
and the rate of cellular NO metabolism (Fig. 2C). The discovery
that NO is metabolized by cells in an O2-dependent manner may
not at ﬁrst seem surprising as it is well-known that NO directly
reacts with O2 (autoxidation, Eq. (10)).
4NOþO2þ2H2O-4Hþþ4NO2 (10)
Rate law: d[NO]/dt ¼4kaq[NO]2[O2]
There are two critical pieces of evidence that rule out auto-
xidation as a signiﬁcant means of NO metabolism. First, the
autoxidation reaction is second-order in NO concentration
whereas the metabolism of NO by cells follows ﬁrst-order
kinetics Eq. (11) [7,8].
d[NO]/dt ¼kobs[O2][NO][Cell] (11)
kobs¼5.38¼70.3104 M1 s1(cell/mL)1
Second, if NO were reacting directly with O2, its rate of dis-
appearance would be exceedingly slow at physiologic NO con-
centrations. Because the rate of NO autoxidation is second-order
with respect to NO, it means that at high NO concentrations, the
Fig. 3. Concentrations of NO and O2 determine the rate autoxidation. Calculated theoretical half-lives of NO via autoxidation at various O2 concentrations based on initial
starting NO concentrations of 50, 100, 200, 500, and 1000 nM. The half-life of a reaction is the amount of time it takes for the concentration of a reactant (NO) to decrease
to one-half of its initial value. These values represent the ﬁrst half-life of NO. Since the autoxidation reaction is a second-order reaction (with respect to the NO con-
centrations), the half-life will change over time as the concentration of NO changes.
Fig. 4. Oxygen determines the concentration of NO and its half-life. (A) The
steady-state concentration of NO is a function of its rate of synthesis relative to its
rate of degradation. (B) Different tissues have different average O2 concentrations.
The half-life of NO changes with respect to the O2 concentration.
Adapted from Ref. [7].
D.D. Thomas / Redox Biology 5 (2015) 225–233 229autoxidation reaction is much faster than at low concentrations.
Fig. 3 illustrates how the half-life of NO via autoxidation changes
over a range of physiologic NO and O2 concentrations. What
should be emphasized is that if the dominant reaction of NO
within cells was directly with O2 (autoxidation), the half-life of NO
would be on the order of hours to days at physiologic NO and O2
concentration. Even when the O2 concentration is high (21%), NO
could last for hours. This is not to say that NO autoxidation does
not occur under biological conditions. Experiments have shown
that this reaction preferentially occurs in hydrophobic environ-
ments such as cell membranes and may be an important source of
reactive nitrogen intermediates (N2O2, NO2) [8,40]. We know,
however, that the biological half-life of NO is short (o2 s),
therefore, autoxidation cannot quantitatively account for the loss
of a signiﬁcant proportion of total NO.
Oxygen determines the steady-state concentration of NO
Oxygen determines the rate of NO synthesis by acting as a
substrate for NOS and it also determines the rate of NO meta-
bolism. Therefore, the local O2 concentration will play a signiﬁcant
role in determining the steady-state concentration of NO
(Fig. 4A). If we think of the steady-state concentration of NO as
water in a bathtub, then the water level will be determined by the
rate of water ﬂow into the tub (NO synthesis) relative to its rate of
ﬂow out of the drain (NO metabolism). Since O2 differentially
controls the rates of both NO synthesis and metabolism, the
steady-state concentration of NO will be a function of the relative
differences in their respective rates. At both the macroscopic and
microscopic level, O2 gradients exist within the human body.
Differences in O2 concentrations can vary widely based on the
organ, tissue, cell type, and even the intercellular location. What
determines the microenvironmental O2 concentration depends on
the rate of O2 delivery from the vasculature as well as the rate of
mitochondrial O2 consumption. Fig. 4B illustrates differences in
the half-life of NO calculated from average tissue O2 concentra-
tions. This model, however, does not take into account the effects
of O2 on NO synthesis only the effect of O2 on the rate of NO
disappearance [7]. It does, however, emphasize how over a range
of physiologic O2 concentrations the biological half-life of NO can
vary signiﬁcantly.
Why is the half-life of NO important? The broad answer is that
it ultimately determines the magnitude of NO signaling. To
properly understand this, it is important to appreciate how NO
moves within the cellular environment, i.e., by diffusion. Nitric
oxide is small and uncharged and is soluble in both hydrophobic
and hydrophilic environments. For these reasons, it is freely dif-
fusible and cell membranes pose no barrier to its movement. Witha relatively large diffusion coefﬁcient (E3800 mm2/s), NO can
travel considerable distances in a short period of time depending
on the local environment (E1 cell length/25 ms) [41]. Once NO is
synthesized, it moves away from its point of origin by random
diffusion (Fig. 5A). Movement of NO in any direction is equally
likely at any point in time, however, net movement of molecules in
one direction will occur if there is a spatial concentration gradient.
The movement will always occur from a region of higher NO
concentration, such as in an NO-producing cell, to a region of
lower NO concentration, an adjacent cell (Fig. 5B) [42].
The distance NO will diffuse is proportional to its concentra-
tion and half-life. This brings up the importance of O2. The O2
concentration is an important determinant of the NO con-
centration, which is a factor in determining how far NO diffuses.
At high O2 concentrations, the half-life of NO is short and so is the
distance it can diffuse. The opposite is true for low O2 concentra-
tions (Fig. 6A). Just as the half-life of NO can be calculated as a
function of O2 concentration, so can its diffusional distance
Fig. 5. Nitric oxide moves by random diffusion. (A) Once NO is synthesized by NOS, it diffuses away in all directions. (B) Net movement of NO occurs from an area of high
concentration (a cell “A” where NO is being made) to a region of lower concentration (“B” surrounding cells). The movement of NO is random but down a concentration
gradient.
D.D. Thomas / Redox Biology 5 (2015) 225–233230(Fig. 6B). It can be seen that differences in physiologic O2 con-
centrations dramatically affect the diffusional distance of NO [7].
This has important implications for predicting the magnitude of
NO signaling under various O2 concentrations. At a high pO2, for
example, the half-life of NO is short and so is the distance it will
diffuse. At low pO2, NO will travel signiﬁcantly longer distances
and potentially exert its inﬂuence many cell lengths away (Fig. 6B).
What this means in terms of cell signaling is that the size of the
diffusional sphere surrounding a NO-producing cell will change
in response to changes in the O2 concentration. This will ulti-
mately determine the amount and types of cellular targets by
changing the number of neighboring cells being affected in a
spatially heterogeneous tissue environment.
Although this discussion has focused on the impact of O2 on
NO bioavailability it would not be complete without mentioning
how NO can affect local O2 concentrations. One of the earlier
discoveries about the biological functions of NO was the obser-
vation that it could inhibit cellular respiration [43]. It was deter-
mined that NO could regulate mitochondrial function and
metabolism through its ability to interact at several sites in the
respiratory chain. This is another example that emphasizes the
importance of NO/metal interactions. At Complex IV (cytochrome
c oxidase) subnanomolar amounts of NO competitively inhibit
respiration. Here NO binds to the ferrous heme-iron or oxidized
copper, but not both simultaneously at the heme iron:copper
binuclear center (a(3)/Cu(B)) [44]. At Complex 1 greater amounts
of NO were shown to be inhibitory but this was attributed to
NO-mediated oxidation or S-nitrosation of speciﬁc thiols [45].
The majority of total body O2 utilization is via its four-electronFig. 6. Oxygen determines the concentration of NO and its diffusional distance. (A) At
metabolized and the greater its steady-state concentration is. At high O2 concentrations,
its half-life as well as its diffusional distance. (B) The O2 concentration determines thereduction to water at mitochondrial complex IV. Inhibition of
mitochondrial respiration by NO, therefore, prevents O2 con-
sumption which extends the half-life of O2. This mechanism is
thought to participate in O2 homeostasis by increasing local O2
delivery from the vascular and extending its delivery into tissues.
Therefore, there is a reciprocal relationship between NO and O2
whereby each molecule plays a role in regulating the concentra-
tion of the other [46].
Oxygen and NO signaling
As we have seen, the O2 concentration is a key determinant of
both the half-life of NO as well as its diffusional distance. These
parameters are important because they inﬂuence signaling
responses to NO. Most cellular targets for NO respond in a
concentration and time dependent manner [47–49]. Numerous
examples have demonstrated that the activation of speciﬁc pro-
teins or the induction of signal transduction cascades respond to
distinct concentration thresholds of NO. For example, soluble
guanylyl cyclase (sGC) is one of the most important biological
targets for NO. It is activated by very low steady-state amounts of
NO ([0.5–5 nM]SS). ERK is another protein that becomes phos-
phorylated in the presence of NO but it requires slightly higher
amounts (4[100 nM]SS). Another class of proteins, non-heme iron
oxygenases, are also targets for NO. These include the HIF prolyl
hydroxylases and the lysine histone demethylase (KDM) enzymes
[28,50]. These are inhibited by intermediate concentrations of NO
([100– 400 nM]SS). Proteins like p53 are regulated by NO at the
upper limits of physiologic concentrations. Phosphorylation of thisa constant rate of NO synthesis, the lower the O2 concentration, the slower NO is
the steady-state NO concentration is lower. The NO concentration will determine
half-life of NO, which inﬂuences how far it will diffuse.
Fig. 7. Oxygen is an upstream driving force of cell phenotype by regulating the NO concentration. Many proteins differ in the threshold amounts of NO necessary for
regulation. Since O2 determines the concentration (dose) of NO, it will indirectly inﬂuence proteins regulated by NO in a concentration-dependent manner. NO-mediated
changes in the protein proﬁle will result in altered cellular phenotypes. This will ultimately have a positive or negative effect on disease outcome.
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(4[500 nM]SS) (Fig. 7).
A long-standing challenge for researchers in the NO ﬁeld has
been to provide plausible mechanisms to explain opposite biolo-
gical responses to NO under seemingly similar circumstances.
There are many physiologic and pathological examples where NO
has been shown to have a positive signaling effect and an equal
number of situations where NO has been shown to have a
negative effect in the same system. For example, NO has
numerous purported roles in cancer etiology [49,51,52]. In some
cases, NO is beneﬁcial in that it decreases tumor size, is cytotoxic,
induces apoptosis, and is an antioxidant. There are other reports,
however, where NO is a negative prognostic indicator by virtue of
its ability to increase angiogenesis, stimulate migration and inva-
sion, and induce DNA damage. The question that is often raised, “is
NO good or bad?”. The answer is “both”. To appreciate how NO
can have such dissimilar and opposing responses, one has to
understand the concentration and temporal-dependent effects of
NO signaling. Differences in tissue O2 concentrations will partially
determine the steady-state concentration of NO. The concentra-
tion of NO will dictate what cellular targets it interacts with. The
types and distributions of cellular targets will determine cell
phenotype, ultimately leading to positive or negative effects on
disease outcome (Fig. 7).
High O2 concentrations will maximize NO production from NOS,
however, it will also increase the rate of NOmetabolism. Conversely,
low O2 concentrations will reduce enzymatic NO synthesis while
also decreasing the rate of NO metabolism. Is there an optimal O2
concentration where a balance between NO production and con-
sumption is achieved to maximize steady-state NO concentrations?
One study showed that the amount of cGMP produced by the acti-
vation of sGC in NO-producing cells was biphasic over a range of O2
concentrations [34]. The maximal amount of cGMP was measured at
an O2 concentration of E8%. The interpretation was that this O2
concentration resulted in the highest steady-state NO concentration
and therefore maximal sGC activation.
Just as the concentration of NO is a key determinant of cell
phenotype, so is the duration of NO exposure. Not only do the
three NOS isoforms produce different amounts of NO, they can
also differ in the duration of synthesis. This becomes important
because some proteins are activated (or inhibited) immediately by
NO whereas others require continuous and sometimes prolonged
NO exposure [47]. Also, the effect of NO on certain proteins isreversible such that they become inactivated (or reactivated) when
the NO source is removed. Yet in other cases, prolonged activation
is achieved long after NO synthesis has ceased. This indicates that
some proteins are real-time NO sensors whose regulation paral-
lels the duration of NO synthesis. In cases where the effects of NO
result in prolonged protein regulation, even short bursts of NO
exposure could have long-lasting phenotypic effects.
Spatial constraints are also contributing factors that inﬂuence
phenotypic responses to NO. As described above, the concentration
of NO will diminish at further distances from its point of synthesis
(Fig. 8). Since most proteins respond to NO in a concentration-
dependent manner, distance will ultimately dictate the population of
targets being regulated by NO. Proteins, with different concentra-
tion threshold requirements for activation by NO, will be differen-
tially regulated depending on their proximity to the NO source. For
example, a protein that requires small amounts of NO like sGC may
be fully activated at locations both near and far from the point of NO
synthesis (Fig. 8, green protein). Whereas a different protein
requiring intermediate amounts of NO (HIF-1α) will be fully acti-
vated when it is close to the point of NO synthesis. At further dis-
tances where the steady-state NO concentration has diminished,
this protein may not be activated at all (Fig. 8, orange protein).
Proteins with the highest NO-concentration requirements such as
p53 may not respond to NO at all regardless of whether they are
proximal or distal to the NO source (Fig. 8, red protein). These
examples demonstrate how spatial differences in the location of
target proteins can dictate phenotypic outcomes based solely on the
differences in their concentration thresholds for activation by NO.
Fig. 9 illustrates the complexities surrounding the interpreta-
tion of phenotypic data from cultured cells treated with NO when
there are differences in both NO concentration and exposure
time. In this simple experiment, cancer cells in culture were
exposed to different concentrations of NO for 48 h and cell via-
bility was measured at 3 separate time points (24, 30, and 48 h). If
the experiment was terminated at 24 h, the interpretation would
be that NO stimulates tumor cell growth (NO is bad). If end-
point measurements were not made until 30 h, the interpretation
might be that NO has no effect on cell viability. However, if the
cells were exposed to NO for a full 48 h before measuring cell
viability, the logical conclusion would be that NO is cytotoxic to
tumor cells (NO is good). Furthermore, if we only looked at low
concentrations of NO (5 mM DETA/NO), the outcome would be
that NO has no effect on tumor cell viability from 0 to 48 h.
Oxygen
Concentration
SignalingDiffusion
Half-life
Nitric oxide
Fig. 10. Oxygen is a dominant and vital regulator of NO chemical biology.
Fig. 8. The location of target proteins relative to the NO source will inﬂuence their
degree of regulation. The concentration of NO diminishes at further distances from
an NO-producing cell (red cell). Proteins requiring small amounts of NO will be
regulated even at distances far away from the NO source (green protein). Proteins
with higher concentration requirements for NO must be closer to the NO source
(orange protein). Proteins requiring high steady-state amounts of NO may not be
regulated at any location within the radius of NO diffusion if the threshold NO
concentration requirement is not achieved (red protein). Green arrows indicate the
regulation, activation, or deactivation by NO (relative sensitivity to NO
green4orange4red protein).
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interpretation would be completely different at every time point.Conclusion
The concepts that have been presented herein are undoubtedly
an oversimpliﬁcation of numerous interrelated complex bio-
chemical and signaling mechanisms of NO. The aim of this short
review, however, was to provide a framework for experimental0 5 50 125 250 500 750 1000
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Fig. 9. Both the concentration and the duration of NO exposure determine the
phenotypic outcome. MDA-MB-231 breast cancer cells were exposed to a range of
physiologic NO concentrations using the NO-donor DETA/NO. DETA/NO has a
long half-life (t½¼22 h), which enables prolonged and continuous NO exposure.
Real-time measurements of cell proliferation was conducted using the xCELLi-
gences DP system (ACEA Biosciences, Inc.) MDA-MB-231 cells were seeded in
E-plates containing 10% serum and allowed to adhere for 12 h before the addition
of NO (5–1000 mM DETA/NO). Cell proliferation was measured continuously for
48 h following NO treatment.design and data interpretation by taking into consideration these
numerous confounding parameters. Although NO may appear to
have contradictory effects under seemingly similar biological
situations, a careful look at the environmental conditions will
often reveal logical explanations for these differences. By under-
standing the importance of O2, target location, NO concentration,
and exposure time on NO signaling responses, it becomes much
easier to comprehend the sheer magnitude of potential outcomes
(Fig. 10). Phenotypic responses attributed to NO suddenly do not
appear to be random at all but rather predictable outcomes that
are simply a reﬂection of the local redox environment. Nitric oxide,
being a free radical, is unique among signaling molecules. It does
not act indiscriminately and it follows the same rules of chemistry
and physics as all molecules. With a better appreciation of its
complex chemical biology, meaningful information will continue
to be discovered about this fascinating and important molecule.Acknowledgements
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